← Back to Search
Effect Of Modification Protocols On The Effectiveness Of Gold Nanoparticles As Drug Delivery Vehicles For Killing Of Breast Cancer Cells
Zahrah Alhalili, Daniela Figueroa, M. Johnston, J. Shapter, B. Sanderson
Published 2016 · Chemistry
Save to my Library
Download PDFAnalyze on Scholarcy
The current study evaluated the potential of gold nanoparticles (AuNPs) for the delivery of Taxol to breast cancer cells (T47D) using an in vitro cell culture model. For this study, new loading approaches and novel chemical attachments were investigated. Five different gold nanoparticle-based complexes were used to determine their cytotoxicity towards T47D cells using the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) viability assay. There was no significant decrease (P > 0.05) in cell viability when T47D cells were treated with AuNPs that did not contain Taxol. However, cells were significantly killed by gold nanoparticles chemically conjugated to Taxol using three different approaches and one novel hybrid AuNP-Taxol nanoparticle, wherein no chemical bonds were involved. These Taxol-loaded AuNPs were more effective at inducing cell death in vitro than a solution of free Taxol used to treat cells. This result demonstrated that Taxol could be released from the particles in the cell culture media for subsequent therapeutic action. Additionally, the experiments proved that the Taxol-loaded AuNPs were more toxic in a dose dependent manner than Taxol as a formulation for the treatment of breast cancer cells. The results of this study suggest that gold nanoparticles have potential for the efficient delivery of Taxol to breast cancer cells. This could provide a future solution as an alternative application method to overcome adverse side effects resulting from current high-dose treatment regimes.
This paper references
Extinction coefficient of gold nanoparticles with different sizes and different capping ligands.
X. Liu (2007)
Characterization, pharmacokinetics and disposition of novel nanoscale preparations of paclitaxel.
C. Wang (2011)
Gezairy, in EMRO Technical Publications Series
H A. (2006)
Ligand density effect on biorecognition by PEGylated gold nanoparticles: regulated interaction of RCA120 lectin with lactose installed to the distal end of tethered PEG strands on gold surface.
Seiji Takae (2005)
Gold nanoparticles surface-functionalized with paclitaxel drug and biotin receptor as theranostic agents for cancer therapy.
D. N. Heo (2012)
Functionalized Gold Nanoparticles and Their Biomedical Applications
P. Tiwari (2011)
Quantitative and Reversible Lectin-Induced Association of Gold Nanoparticles Modified with α-Lactosyl-ω-mercapto-poly(ethylene glycol)
H. Otsuka (2001)
Nanotechnology in diagnostics and therapeutics for gastrointestinal disorders.
H. Laroui (2013)
The reliability and limits of the MTT reduction assay for carbon nanotubes-cell interaction
L. Belyanskaya (2007)
Phase III trial of nanoparticle albumin-bound paclitaxel compared with polyethylated castor oil-based paclitaxel in women with breast cancer.
W. Gradishar (2005)
Engineering erythrocytes as a novel carrier for the targeted delivery of the anticancer drug paclitaxel.
G. I. Harisa (2014)
Improved biochemical strategies for targeted delivery of taxoids.
T. Ganesh (2007)
Design of multifunctional gold nanoparticles for in vitro and in vivo gene silencing.
João Conde (2012)
Polymer size and concentration effects on the size of gold nanoparticles capped by polymeric thiols.
Robert G. Shimmin (2004)
Biomechanical properties of carbodiimide crosslinked collagen: influence of the formation of ester crosslinks.
F. Everaerts (2008)
Paclitaxel-functionalized gold nanoparticles.
J. Gibson (2007)
D. Granchi (1996)
In vitro toxicology of respirable Montserrat volcanic ash
M. Wilson (2000)
Recent Advances in Drug Delivery Systems
N. Martinho (2011)
NMR characterization of paclitaxel/poly (styrene-isobutylene-styrene) formulations.
Jian-zhong Chen (2005)
In vitro toxicity of nanoparticles in BRL 3A rat liver cells.
S. Hussain (2005)
The performance of thiol-terminated PEG-paclitaxel-conjugated gold nanoparticles.
Y. Ding (2013)
Targeted Paclitaxel by conjugation to iron oxide and gold nanoparticles.
J. R. Hwu (2009)
Nanotechnology-Based Drug Delivery Systems for Targeting, Imaging and Diagnosis of Neurodegenerative Diseases
S. Pehlivan (2013)
Application of nanotechnology in biomedicine.
Rajshri M Navalakhe (2007)
Design and characterization of antitumor drug paclitaxel-loaded chitosan nanoparticles by W/O emulsions.
J. Xu (2012)
Emerging application of quantum dots for drug delivery and therapy
Lifeng Qi (2008)
Two-Step Functionalization of Neutral and Positively Charged Thiols onto Citrate-Stabilized Au Nanoparticles
Shu-Yi Lin (2004)
Application of Nanotechnology in Cancer Therapy and Imaging
X. Wang (2008)
Gold nanoparticles with a polymerizable surfactant bilayer: synthesis, polymerization, and stability evaluation.
A. AlKilany (2009)
Solubility and stability of taxol: effects of buffers and cyclodextrins
S. Dordunoo (1996)
Low molecular weight polyethylene glycol induces chromosome aberrations in Chinese hamster cells cultured in vitro.
O. Biondi (2002)
Biodegradable multiblock poly(N-2-hydroxypropyl)methacrylamide gemcitabine and paclitaxel conjugates for ovarian cancer cell combination treatment.
N. Larson (2013)
Miss A.O. Penney (1974)
In vitro biological effects of sodium titanate materials.
R. R. Davis (2007)
Novel free paclitaxel-loaded poly(L-γ-glutamylglutamine)–paclitaxel nanoparticles
Danbo Yang (2011)
Assessment of metal extract toxicity on human lymphocytes cultured in vitro.
D. Granchi (1996)
Solid lipid nanoparticles as drug carriers. I. Incorporation and retention of the lipophilic prodrug 3′-azido-3′-deoxythymidine palmitate
H. Heiati (1997)
Gold nanoparticles of diameter 1.4 nm trigger necrosis by oxidative stress and mitochondrial damage.
Y. Pan (2009)
Measurement of paclitaxel and its metabolites in human plasma using liquid chromatography/ion trap mass spectrometry with a sonic spray ionization interface.
H. Gréen (2006)
Breast cancer statistics, 2013
C. Desantis (2014)
The Potential of Gold Nanoparticle Conjugates to Kill Cancer Cells in Culture
B. Sanderson (2014)
Current in vitro methods in nanoparticle risk assessment: limitations and challenges.
A. Kroll (2009)
Outcome of advanced nonsmall cell lung cancer patients receiving gemcitabine and weekly paclitaxel as first-line treatment.
Z. Lin (2008)
Gold nanoparticles as novel agents for cancer therapy.
S. Jain (2012)
Assessing toxicity of fine and nanoparticles: comparing in vitro measurements to in vivo pulmonary toxicity profiles.
C. Sayes (2007)
Immobilization of glucose oxidase onto gold nanoparticles with enhanced thermostability.
D. Li (2007)
Superparamagnetic iron oxide nanoparticles: magnetic nanoplatforms as drug carriers
Poly(ethylene glycol) in drug delivery: pros and cons as well as potential alternatives.
Katrin Knop (2010)
Epidemiology of breast cancer.
T. Key (2001)
Gold nanoparticles are taken up by human cells but do not cause acute cytotoxicity.
E. E. Connor (2005)
A randomized phase II study of paclitaxel and bevacizumab with and without gemcitabine as first-line treatment for metastatic breast cancer.
A. Brufsky (2011)
Tetrazolium dyes as tools in cell biology: new insights into their cellular reduction.
M. Berridge (2005)
A simple spectroscopic method for differentiating cellular uptakes of gold nanospheres and nanorods from their mixtures.
E. Cho (2010)
Preparation and Characterization of Au Colloid Monolayers
K. C. Grabar (1995)
E. C. Cho (1976)
Toxicity of gold nanoparticles functionalized with cationic and anionic side chains.
Catherine M Goodman (2004)
A study of the nucleation and growth processes in the synthesis of colloidal gold
J. Turkevich (1951)
An investigation of common crosslinking agents on the stability of electrospun collagen scaffolds.
G. P. Huang (2015)
Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays.
T. Mosmann (1983)
This paper is referenced by
Synthesis of gold nanomaterials and their cancer-related biomedical applications: an update
S. Govindaraju (2018)
Celebrating RACI and Academy of Science Awards
C. Wentrup (2016)
Gold nanorods–trypsin biocorona: a novel nano composite for in vitro cytotoxic activity towards MCF-7 and A-549 cancer cells
Kandoth Kandy Jesna (2020)
Evaluation of the Secondary Metabolites of the Waste Pomegranate Rind and its Cytotoxicity against Oral Cancer (KB 3-1)
T. JesseJoel (2019)
Mechanistic investigation of cellular internalization routes of polymeric particles on breast cancer cells: relevance for drug delivery applications
Meirong Zhou (2020)
Curcumin-Conjugated Gold Clusters for Bioimaging and Anticancer Applications.
S. Govindaraju (2018)
The Potential of Algae Spyrogyra peipingensis to Produce Nanogold in Batch Culture Medium
Arbaina Syahdinnur (2018)
Nanoparticles for Detection, Diagnostics, and Targeting using Hyperspectral Imaging
David Baah (2017)